drugset / Trial / NCT00942344

Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension

NCT00942344

Phase 2 Completed 320 enrolled Hanmi Pharmaceutical Company Limited
RandomizedFactorialDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of fixed combination of amlodipine(5mg or 10mg) and losartan (50 mg or 100 mg), amlodipine and losartan alone in reducing blood pressure. The study will investigate the dose response relationship for the combinations and monotherapies.

Timeline

Start
2007-05
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg
Subject Amlodipine Other / unclassified 10 mg
Subject Losartan Other / unclassified 50 mg
Subject Losartan Other / unclassified 100 mg